You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-FGF9 antibody [FG9-77] (ab10424)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-FGF9 antibody [FG9-77]
See all FGF9 products (7) ...

Description

Mouse monoclonal [FG9-77] to FGF9

Specificity

Monoclonal Anti-FGF9 reacts specifically with recombinant FGF9 (fibroblast growth factor 9). It does not cross-react with human FGF Acidic and FGF Basic.

Tested applications

ELISA, Dot Blot, WBmore details

Cross reactivity

Reacts with

Mouse, Human

Immunogen

Recombinant full length protein (Mouse).

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 0.01M PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Monoclonal

Clone number

FG9-77

Isotype

IgG1

Applications

Show applications key

Our Abpromise guarantee covers the use of ab10424 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide

    ELISA

     ELISA: Use at an assay d...Read more →

    ELISA: Use at an assay dependent dilution.

  • ShowHide

    Dot Blot

     Dot: Use a concentration...Read more →

    Dot: Use a concentration of 5 µg/ml

  • ShowHide

    WB

     WB: Use at an assay depe...Read more →

    WB: Use at an assay dependent dilution. Detects a band of approximately 25 kDa.

Target

Function

May have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors.

Tissue specificity

Glial cells.

Involvement in disease

Defects in FGF9 are the cause of multiple synostoses syndrome type 3 (SYNS3) [MIM:612961]. Multiple synostoses syndrome is an autosomal dominant condition characterized by progressive joint fusions of the fingers, wrists, ankles and cervical spine, characteristic facies and progressive conductive deafness.

Sequence similarities

Belongs to the heparin-binding growth factors family.

Post-translational
modifications

Three molecular species were found (30 kDa, 29 kDa and 25 kDa), cleaved at Leu-4, Val-13 and Ser-34 respectively. The smaller ones might be products of proteolytic digestion. Furthermore, there may be a functional signal sequence in the 30 kDa species which is uncleavable in the secretion step.
N-glycosylated.

Cellular localization

Secreted.

Target information above from: UniProt accessionP31371 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • FGF 9 antibody
  • FGF-9 antibody
  • FGF9 antibody
  • FGF9_HUMAN antibody
  • Fibroblast Growth Factor 9 antibody
  • GAF antibody
  • Glia Activating Factor antibody
  • Glia-activating factor antibody
  • HBFG 9 antibody
  • HBFG9 antibody
  • HBGF-9 antibody
  • Heparin-binding growth factor 9 antibody
  • MGC119914 antibody
  • MGC119915 antibody
see all

References for Anti-FGF9 antibody [FG9-77] (ab10424)

ab10424 has not yet been referenced specifically in any publications.

Publishing research using ab10424? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"